• Association of high serum levels of growth factors with good outcome in ischemic stroke: a multicenter study 

      Sobrino, Tomás; Rodríguez-Yáñez, Manuel; Campos, Francisco; Iglesias-Rey, Ramón; Millán, Mónica; Pérez de la Osa, Natalia; Dávalos, Antonio; Delgado-Mederos, Raquel; Martínez-Domeño, Alejandro; Martí-Fábregas, Joan; Castellanos, María del Mar; Serena, Joaquín; Lago, Aida; Díez-Tejedor, Exuperio; Castillo, José (Springer Nature, 2019-11-25)
      [Abstract] The main objective of this research work was to study the association of serum levels of growth factors (GF) and SDF-1α with the functional outcome and reduction of lesion volume in ischemic stroke patients. In ...
    • RP11-362K2.2:RP11-767I20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma: a GWAS meta-analysis 

      Muiño, Elena; Cárcel-Márquez, Jara; Carrera, Caty; Llucià-Carol, Laia; Gallego-Fábrega, Cristina; Cullel, Natalia; Lledós, Miquel; Castillo, José; Sobrino, Tomás; Campos, Francisco; Rodríguez-Castro, Emilio; Millán, Mónica; Muñoz-Narbona, Lucía; Bustamante, Alejandro; López-Cancio Martínez, Elena; Ribó, Marc; Álvarez-Sabín, José; Jiménez-Conde, Jordi; Roquer, Jaume; Giralt-Steinhauer, Eva; Soriano-Tárraga, Carolina; Vives-Bauza, Cristófol; Díaz Navarro, Rosa; Tur, Silvia; Obach, Victor; Arenillas, Juan; Segura, Tomás; Serrano-Heras, Gemma; Martí-Fàbregas, Joan; Delgado-Mederos, Raquel; Camps-Renom, Pol; Prats-Sánchez, Luis; Guisado, Daniel; Guasch, Marina; Marin, Rebeca; Martínez-Domeño, Alejandro; Freijo Guerrero, María del Mar; Moniche Álvarez, Francisco; Cabezas, Juan Antonio; Castellanos, María del Mar; Krupinsky, Jerzy; Strbian, Daniel; Tatlisumak, Turgut; Thijs, Vincent; Lemmens, Robin; Slowik, Agnieszka; Pera, Joanna; Heitsch, Laura; Ibáñez, Laura; Cruchaga, Carlos; Dhar, Rajat; Lee, Jin-Moo; Montaner, Joan; Fernández-Cadenas, Israel (MDPI, 2021-07-16)
      [Abstract] Stroke is one of the most common causes of death and disability. Reperfusion therapies are the only treatment available during the acute phase of stroke. Due to recent clinical trials, these therapies may increase ...